Harmony Biosciences Holdings Inc
HRMY
Market Cap$1.97B
Close$
Share Statistics
| Market cap | $1.97 Billion |
|---|---|
| Enterprise Value | $1.53 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.17 |
| Beta | 0.73 |
| Outstanding Shares | 56,802,357 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.09 |
|---|---|
| PEG | 86.13 |
| Price to Sales | 2.46 |
| Price to Book Ratio | 2.68 |
| Enterprise Value to Revenue | 2.24 |
| Enterprise Value to EBIT | 7.84 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Harmony Biosciences Holdings Inc
150 employeesHarmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.